Galmed Pharmaceuticals

$3.06
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-3.46%) Today
-$0.01 (-0.33%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell GLMD and other stocks, options, and ETFs commission-free!

About GLMD

Galmed Pharmaceuticals Ltd. Ordinary Shares, also called Galmed Pharmaceuticals, is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH).

CEO
Allen Baharaff
Employees
24
Headquarters
Tel Aviv, Tel Aviv
Founded
2000
Market Cap
77.25M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
153.66K
High Today
$3.19
Low Today
$3.03
Open Price
$3.16
Volume
279.06K
52 Week High
$6.29
52 Week Low
$2.96

GLMD Earnings

-$0.48
-$0.32
-$0.16
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, Pre-Market

You May Also Like

RCHGW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure